209 related articles for article (PubMed ID: 12865927)
21. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
Lee TL; Yeh J; Van Waes C; Chen Z
Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
[TBL] [Abstract][Full Text] [Related]
22. Suppressor of cytokine signalling gene expression is elevated in breast carcinoma.
Raccurt M; Tam SP; Lau P; Mertani HC; Lambert A; Garcia-Caballero T; Li H; Brown RJ; McGuckin MA; Morel G; Waters MJ
Br J Cancer; 2003 Aug; 89(3):524-32. PubMed ID: 12888825
[TBL] [Abstract][Full Text] [Related]
23. Activity of the suppressor of cytokine signaling-3 promoter in human non-small-cell lung cancer.
He B; You L; Xu Z; Mazieres J; Lee AY; Jablons DM
Clin Lung Cancer; 2004 May; 5(6):366-70. PubMed ID: 15217536
[TBL] [Abstract][Full Text] [Related]
24. Methylation-mediated gene silencing of suppressor of cytokine signaling-1 (SOCS-1) gene in esophageal squamous cell carcinoma patients of Kashmir valley.
Hussain S; Singh N; Salam I; Bandil K; Yuvaraj M; Akbar Bhat M; Muzaffar Mir M; Siddiqi MA; Sobti RC; Bharadwaj M; Das BC
J Recept Signal Transduct Res; 2011 Apr; 31(2):147-56. PubMed ID: 21385099
[TBL] [Abstract][Full Text] [Related]
25. Hypermethylation of the suppressor of cytokine signalling-1 (SOCS-1) in myelodysplastic syndrome.
Brakensiek K; Länger F; Schlegelberger B; Kreipe H; Lehmann U
Br J Haematol; 2005 Jul; 130(2):209-17. PubMed ID: 16029449
[TBL] [Abstract][Full Text] [Related]
26. Combined hypermethylation and chromosome loss associated with inactivation of SSI-1/SOCS-1/JAB gene in human hepatocellular carcinomas.
Nagai H; Kim YS; Konishi N; Baba M; Kubota T; Yoshimura A; Emi M
Cancer Lett; 2002 Dec; 186(1):59-65. PubMed ID: 12183076
[TBL] [Abstract][Full Text] [Related]
27. SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer.
He B; You L; Uematsu K; Zang K; Xu Z; Lee AY; Costello JF; McCormick F; Jablons DM
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14133-8. PubMed ID: 14617776
[TBL] [Abstract][Full Text] [Related]
28. Expression of SOCS-1, suppressor of cytokine signalling-1, in human melanoma.
Li Z; Metze D; Nashan D; Müller-Tidow C; Serve HL; Poremba C; Luger TA; Böhm M
J Invest Dermatol; 2004 Oct; 123(4):737-45. PubMed ID: 15373779
[TBL] [Abstract][Full Text] [Related]
29. Effect of Decitabine (5-aza-2'-deoxycytidine, 5-aza-CdR) in Comparison with Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) on DNMT1, DNMT3a and DNMT3b, HDAC 1-3, SOCS 1, SOCS 3, JAK2, and STAT3 Gene Expression in Hepatocellular Carcinoma HLE and LCL-PI 11 Cell Lines.
Sanaei M; Kavoosi F; Pourahmadi M
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2089-2098. PubMed ID: 34319031
[TBL] [Abstract][Full Text] [Related]
30. GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas.
Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
Virchows Arch; 2015 Jun; 466(6):665-74. PubMed ID: 25796395
[TBL] [Abstract][Full Text] [Related]
31. Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice.
Kopp JL; Dubois CL; Schaeffer DF; Samani A; Taghizadeh F; Cowan RW; Rhim AD; Stiles BL; Valasek M; Sander M
Gastroenterology; 2018 Apr; 154(5):1509-1523.e5. PubMed ID: 29273451
[TBL] [Abstract][Full Text] [Related]
32. Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway.
Cooney RN
Shock; 2002 Feb; 17(2):83-90. PubMed ID: 11837794
[TBL] [Abstract][Full Text] [Related]
33. Differential hypermethylation of SOCS genes in ovarian and breast carcinomas.
Sutherland KD; Lindeman GJ; Choong DY; Wittlin S; Brentzell L; Phillips W; Campbell IG; Visvader JE
Oncogene; 2004 Oct; 23(46):7726-33. PubMed ID: 15361843
[TBL] [Abstract][Full Text] [Related]
34. Aberrant methylation of the Human Hedgehog interacting protein (HHIP) gene in pancreatic neoplasms.
Martin ST; Sato N; Dhara S; Chang R; Hustinx SR; Abe T; Maitra A; Goggins M
Cancer Biol Ther; 2005 Jul; 4(7):728-33. PubMed ID: 15970691
[TBL] [Abstract][Full Text] [Related]
35. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma.
Jiang P; Watanabe H; Okada G; Ohtsubo K; Mouri H; Tsuchiyama T; Yao F; Sawabu N
Cancer Sci; 2006 Nov; 97(11):1267-73. PubMed ID: 16965396
[TBL] [Abstract][Full Text] [Related]
37. SOCS3 methylation in synergy with Reg3A overexpression promotes cell growth in pancreatic cancer.
Wang J; Zhou H; Han Y; Liu X; Wang M; Wang X; Yin G; Li X; Xiang M
J Mol Med (Berl); 2014 Dec; 92(12):1257-69. PubMed ID: 24996521
[TBL] [Abstract][Full Text] [Related]
38. Abundant hypermethylation of SOCS-1 in clinically silent pituitary adenomas.
Buslei R; Kreutzer J; Hofmann B; Schmidt V; Siebzehnrübl F; Hahnen E; Eyupoglu IY; Fahlbusch R; Blümcke I
Acta Neuropathol; 2006 Mar; 111(3):264-71. PubMed ID: 16421738
[TBL] [Abstract][Full Text] [Related]
39. Preliminary study analyzing the methylated genes in the plasma of patients with pancreatic cancer.
Park JW; Baek IH; Kim YT
Scand J Surg; 2012; 101(1):38-44. PubMed ID: 22414467
[TBL] [Abstract][Full Text] [Related]
40. Combined Analysis of the Aberrant Epigenetic Alteration of Pancreatic Ductal Adenocarcinoma.
Xu R; Xu Q; Huang G; Yin X; Zhu J; Peng Y; Song J
Biomed Res Int; 2019; 2019():9379864. PubMed ID: 31956659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]